Modulation of the expression of ABC transporters in murine (J774) macrophages exposed to large concentrations of the fluoroquinolone antibiotic moxifloxacin

Toxicology

Volumn 290, Issue 2-3, 2011, Pages 178-186

  Vallet, Coralie M ^a   Marquez, Béatrice ^a,c   Nhiri, Naïma ^b   Anantharajah, Ahalieyah ^a   Mingeot Leclercq, Marie Paule ^a   Tulkens, Paul M ^a   Lallemand, Jean Yves ^b   Jacquet, Eric ^b   Van Bambeke, Françoise ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

^c Instituto de Biomedicina de Sevilla   (Spain)

Author keywords

Bcrp; Ciprofloxacin; Efflux; Moxifloxacin; Mrp4; P gp

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CIPROFLOXACIN; MOXIFLOXACIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; DRUG ACCUMULATION; DRUG EXPOSURE; DRUG MEGADOSE; GENE OVEREXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MURINAE;

EID: 84858616945     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.09.003     Document Type: Article

References (47)

1. Alvarez A.I., Perez M., Prieto J.G., Molina A.J., Real R., Merino G. Fluoroquinolone efflux mediated by ABC transporters. J. Pharm. Sci. 2008, 97:3483-3493.
2. Ando T., Kusuhara H., Merino G., Alvarez A.I., Schinkel A.H., Sugiyama Y. Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones. Drug Metab. Dispos. 2007, 35:1873-1879.
3. Annilo T., Chen Z.Q., Shulenin S., Dean M. Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. Mamm. Genome 2003, 14:7-20.
4. Anonymous, 2008. Avelox Package insert. 11.11.2008. http://www.univgraph.com/bayer/inserts/avelox.pdf.
5. Baguley B.C. Multiple drug resistance mechanisms in cancer. Mol. Biotechnol. 2010, 46:308-316.
6. Bensikaddour H., Fa N., Burton I., Deleu M., Lins L., Schanck A., Brasseur R., Dufrene Y.F., Goormaghtigh E., Mingeot-Leclercq M.P. Characterization of the interactions between fluoroquinolone antibiotics and lipids: a multitechnique approach. Biophys. J. 2008, 94:3035-3046.
7. Brillault J., De Castro W.V., Harnois T., Kitzis A., Olivier J.C., Couet W. P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model. Antimicrob. Agents Chemother. 2009, 53:1457-1462.
8. + channels. Pflugers Arch. 2007, 453:703-718.
9. Cormet-Boyaka E., Huneau J.F., Mordrelle A., Boyaka P.N., Carbon C., Rubinstein E., Tome D. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob. Agents Chemother. 1998, 42:2607-2611.
10. Eckford P.D., Sharom F.J. ABC efflux pump-based resistance to chemotherapy drugs. Chem. Rev. 2009, 109:2989-3011.
11. Eytan G.D., Regev R., Oren G., Assaraf Y.G. The role of passive transbilayer drug movement in multidrug resistance and its modulation. J. Biol. Chem. 1996, 271:12897-12902.
12. Fardel O., Payen L., Courtois A., Vernhet L., Lecureur V. Regulation of biliary drug efflux pump expression by hormones and xenobiotics. Toxicology 2001, 167:37-46.
13. Fontaine M., Elmquist W.F., Miller D.W. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sci. 1996, 59:1521-1531.
14. Gillet J.P., Efferth T., Remacle J. Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim. Biophys. Acta 2007, 1775:237-262.
15. Gillet J.P., Efferth T., Steinbach D., Hamels J., de Longueville F., Bertholet V., Remacle J. Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res. 2004, 64:8987-8993.
16. Ginsberg A.M. Drugs in development for tuberculosis. Drugs 2010, 70:2201-2214.
17. Gottesman M.M., Cardarelli C., Goldenberg S., Licht T., Pastan I. Selection and maintenance of multidrug-resistant cells. Methods Enzymol. 1998, 292:248-258.
18. Herget M., Tampe R. Intracellular peptide transporters in human-compartmentalization of the " peptidome" . Pflugers Arch. 2007, 453:591-600.
19. Huggett J., Dheda K., Bustin S., Zumla A. Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 2005, 6:279-284.
20. Klaassen C.D., Aleksunes L.M. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol. Rev. 2010, 62:1-96.
21. Lowes S., Simmons N.L. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 2002, 135:1263-1275.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
23. Marbeuf-Gueye C., Ettori D., Priebe W., Kozlowski H., Garnier-Suillerot A. Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein. Biochim. Biophys. Acta 1999, 1450:374-384.
24. Marquez B., Caceres N.E., Mingeot-Leclercq M.P., Tulkens P.M., Van Bambeke F. Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells. Antimicrob. Agents Chemother. 2009, 53:2410-2416.
25. Michot J.M., Heremans M.F., Caceres N.E., Mingeot-Leclercq M.P., Tulkens P.M., Van Bambeke F. Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophages. Antimicrob. Agents Chemother. 2006, 50:1689-1695.
26. Michot J.M., Seral C., Van Bambeke F., Mingeot-Leclercq M.P., Tulkens P.M. Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages. Antimicrob. Agents Chemother. 2005, 49:2429-2437.
27. Michot J.M., Van Bambeke F., Mingeot-Leclercq M.P., Tulkens P.M. Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter. Antimicrob. Agents Chemother. 2004, 48:2673-2682.
28. Perrone C.E., Takahashi K.C., Williams G.M. Inhibition of human topoisomerase IIalpha by fluoroquinolones and ultraviolet A irradiation. Toxicol. Sci. 2002, 69:16-22.
29. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
30. Piehler A., Kaminski W.E., Wenzel J.J., Langmann T., Schmitz G. Molecular structure of a novel cholesterol-responsive A subclass ABC transporter, ABCA9. Biochem. Biophys. Res. Commun. 2002, 295:408-416.
31. Pulido M.M., Molina A.J., Merino G., Mendoza G., Prieto J.G., Alvarez A.I. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. J. Vet. Pharmacol. Ther. 2006, 29:279-287.
32. Reuveni D., Halperin D., Shalit I., Priel E., Fabian I. Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects. Biochem. Pharmacol. 2008, 75:1272-1281.
33. Robey R.W., Honjo Y., van de L.A., Miyake K., Regis J.T., Litman T., Bates S.E. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim. Biophys. Acta 2001, 1512:171-182.
34. Schrickx J.A., Fink-Gremmels J. Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. Br. J. Pharmacol. 2007, 150:463-469.
35. Scotto K.W. Transcriptional regulation of ABC drug transporters. Oncogene 2003, 22:7496-7511.
36. Seral C., Carryn S., Tulkens P.M., Van Bambeke F. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. J. Antimicrob. Chemother. 2003, 51:1167-1173.
37. Stass H., Kubitza D. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man. J. Antimicrob. Chemother. 1999, 43(Suppl. B):83-90.
38. Takara K., Tsujimoto M., Kokufu M., Ohnishi N., Yokoyama T. Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cells. Biol. Pharm. Bull. 2003, 26:205-209.
39. Tsuruoka S., Ishibashi K., Yamamoto H., Wakaumi M., Suzuki M., Schwartz G.J., Imai M., Fujimura A. Functional analysis of ABCA8, a new drug transporter. Biochem. Biophys. Res. Commun. 2002, 298:41-45.
40. Turk D., Hall M.D., Chu B.F., Ludwig J.A., Fales H.M., Gottesman M.M., Szakacs G. Identification of compounds selectively killing multidrug-resistant cancer cells. Cancer Res. 2009, 69:8293-8301.
41. Vallet C.M., Marquez B., Ngabirano E., Lemaire S., Mingeot-Leclercq M.P., Tulkens P.M., Van Bambeke F. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages. Int. J. Antimicrob. Agents 2011, 38:249-256.
42. Van Bambeke F., Barcia-Macay M., Lemaire S., Tulkens P.M. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr. Opin. Drug Discov. Devel. 2006, 9:218-230.
43. Wagenlehner F.M., Kees F., Weidner W., Wagenlehner C., Naber K.G. Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400mg to healthy volunteers. Int. J. Antimicrob. Agents 2008, 31:21-26.
44. Wang X., Collins H.L., Ranalletta M., Fuki I.V., Billheimer J.T., Rothblat G.H., Tall A.R., Rader D.J. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 2007, 117:2216-2224.
45. Xu C., Li C.Y., Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 2005, 28:249-268.
46. Yabuki N., Sakata K., Yamasaki T., Terashima H., Mio T., Miyazaki Y., Fujii T., Kitada K. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance. Cancer Genet. Cytogenet. 2007, 173:1-9.
47. Zhang F., Zhang W., Liu L., Fisher C.L., Hui D., Childs S., Dorovini-Zis K., Ling V. Characterization of ABCB9, an ATP binding cassette protein associated with lysosomes. J. Biol. Chem. 2000, 275:23287-23294.